Our Pricing

Comparing Acid Reflux Treatment Options

Published on: June 03, 2026

When comparing acid reflux treatments UK options, understanding the differences between proton pump inhibitors (PPIs) helps you make an informed choice. At Cured Pharmacy, our UK-registered clinical team assess your symptoms and recommend the most suitable treatment from our range of licensed medications, starting from £9.99.

Understanding Proton Pump Inhibitors for Acid Reflux

Proton pump inhibitors represent the gold standard for treating gastro-oesophageal reflux disease (GORD) in the UK, licensed by the MHRA for both short-term symptom relief and long-term management [1]. These medications work by blocking the enzyme system responsible for producing stomach acid, reducing acid secretion by up to 90% within 24 hours of the first dose.

Unlike antacids that neutralise existing acid or H2 receptor antagonists that partially reduce acid production, PPIs provide more profound and sustained acid suppression [2]. This makes them particularly effective for patients experiencing frequent heartburn, regurgitation, or oesophageal inflammation that hasn't responded adequately to other treatments.

The five main PPIs available in the UK—omeprazole, lansoprazole, pantoprazole, esomeprazole, and rabeprazole—share the same mechanism of action but differ in their molecular structure, metabolism, and individual patient response [1]. Most patients achieve symptom control within 2-4 weeks, though your UK prescriber may adjust treatment duration based on symptom severity and underlying causes.

Omeprazole vs Lansoprazole: First-Line Treatment Comparison

Omeprazole and lansoprazole are the most commonly prescribed PPIs in the UK, both offering excellent efficacy for acid reflux management. Clinical trials demonstrate that both medications heal oesophageal erosions in approximately 80-85% of patients after 8 weeks of treatment [2][3].

The primary difference lies in their formulation and onset of action. Lansoprazole capsules contain enteric-coated granules that dissolve slightly faster, potentially offering marginally quicker symptom relief in some patients. Omeprazole, available in both capsule and tablet forms, has the longest track record of safety data spanning over three decades of clinical use.

At Cured Pharmacy, omeprazole starts from £9.99, making it the most cost-effective PPI option for UK patients. Lansoprazole is available from £9.99, with both medications requiring the same once-daily dosing schedule. Your prescriber will consider factors including previous treatment response, concurrent medications, and individual tolerance when recommending between these options.

Dosage Flexibility and Treatment Duration

Both omeprazole and lansoprazole are available in multiple strengths at Cured Pharmacy. Omeprazole comes in 10mg and 20mg capsules, whilst lansoprazole is available in 15mg and 30mg formulations. Standard treatment typically begins with 20mg omeprazole or 30mg lansoprazole once daily, taken 30 minutes before breakfast for optimal absorption [1].

For mild, intermittent symptoms, lower-dose options may provide adequate control. Patients with more severe GORD or Barrett's oesophagus may require higher doses or twice-daily administration, though this must be determined by your UK prescriber following clinical assessment.

Esomeprazole and Pantoprazole: Advanced PPI Options

Esomeprazole, the S-isomer of omeprazole, offers enhanced acid suppression through improved pharmacokinetic properties. Clinical trials show esomeprazole 40mg provides faster healing of erosive oesophagitis compared to omeprazole 20mg, with healing rates of 94% versus 86% at 8 weeks respectively [4].

Pantoprazole distinguishes itself through its unique metabolism pathway, making it particularly suitable for patients taking multiple medications. Unlike other PPIs, pantoprazole undergoes predominantly phase II conjugation rather than cytochrome P450 metabolism, reducing the risk of drug-drug interactions [3]. This makes it a preferred choice for elderly patients or those with complex medication regimens.

At Cured Pharmacy, esomeprazole 20mg is available from £9.99, whilst pantoprazole gastro-resistant tablets start from £9.99 in both 20mg and 40mg strengths. Both medications require once-daily dosing and should be taken at the same time each day for consistent acid control throughout the 24-hour period.

When to Consider Alternative PPIs

Approximately 10-15% of patients experience inadequate symptom control with their initial PPI, a phenomenon known as PPI-refractory GORD [2]. In these cases, switching to an alternative PPI can provide better results, as individual response varies based on genetic factors affecting drug metabolism.

Your UK prescriber may recommend switching PPIs if you haven't achieved satisfactory symptom relief after 4-8 weeks of treatment, or if you experience persistent side effects. Factors including dosing timing, adherence to pre-meal administration, and lifestyle modifications all influence treatment success and should be reviewed before changing medications.

Comparing Acid Reflux Treatments: Branded vs Generic Medications

Generic PPIs contain the same active pharmaceutical ingredient as branded versions and meet identical MHRA standards for quality, safety, and efficacy. At Cured Pharmacy, both generic omeprazole (from £9.99) and branded options like Losec (from £9.99) undergo the same rigorous manufacturing and quality control processes.

Branded medications such as Nexium (esomeprazole) and Zoton FasTab (lansoprazole) may offer convenience features like faster-dissolving formulations or alternative delivery methods. Zoton FasTab, available from £9.99, dissolves on the tongue without water, making it suitable for patients with swallowing difficulties or those seeking greater dosing flexibility.

Pyrocalm, available from £9.99, contains omeprazole 20mg and is licensed for short-term treatment of reflux symptoms in adults. Whilst chemically identical to prescription omeprazole, over-the-counter products like Pyrocalm are intended for 2-week courses only. Longer treatment periods require clinical assessment to rule out underlying conditions and ensure appropriate ongoing management [1].

Treatment Selection Based on Symptom Severity

Mild, infrequent acid reflux occurring less than twice weekly may respond adequately to on-demand PPI therapy or lower-dose formulations. Clinical guidelines from NICE recommend starting with the lowest effective dose and stepping down once symptoms are controlled [3].

Moderate to severe GORD, characterised by daily symptoms, nocturnal reflux, or confirmed oesophageal inflammation, typically requires continuous PPI therapy at standard doses. Studies show that 70-80% of patients with erosive oesophagitis relapse within 6 months of stopping treatment, necessitating long-term maintenance therapy in many cases [4].

Patients with alarm symptoms—including difficulty swallowing, unintentional weight loss, persistent vomiting, or gastrointestinal bleeding—require urgent medical evaluation before starting treatment. Your UK prescriber will screen for these red-flag symptoms during your online consultation and arrange appropriate referral if needed. All prescription medications at Cured Pharmacy require clinical assessment by a UK-registered prescriber to ensure safe, appropriate treatment selection.

Lifestyle Modifications to Enhance Treatment Efficacy

Combining PPI therapy with lifestyle changes significantly improves treatment outcomes. Evidence shows that elevating the head of the bed by 15-20cm, avoiding meals within 3 hours of bedtime, and reducing portion sizes can decrease nocturnal acid exposure by up to 67% [2].

Weight loss in overweight patients, smoking cessation, and limiting alcohol and caffeine intake all contribute to better symptom control. However, these modifications complement rather than replace pharmacological treatment in patients with established GORD, and medication remains necessary for adequate acid suppression in most cases.

Safety Considerations and Long-Term PPI Use

PPIs have an excellent safety profile, with most patients tolerating them well for extended periods. Common side effects—including headache, nausea, and abdominal pain—occur in fewer than 5% of patients and are typically mild and transient [1].

Recent research has examined potential risks associated with long-term PPI use, including reduced absorption of vitamin B12, magnesium, and calcium. Whilst these effects are documented, clinically significant deficiencies remain uncommon, occurring in fewer than 2% of long-term users [3]. Your UK prescriber may recommend periodic monitoring if you require continuous treatment beyond 12 months.

The benefits of PPI therapy in preventing complications of untreated GORD—including oesophageal stricture, Barrett's oesophagus, and oesophageal adenocarcinoma—substantially outweigh potential risks for most patients [4]. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all patients receive appropriate counselling on safe medication use and when to seek further medical review.

Scientific References

1. Strand, D. S., Kim, D., & Peura, D. A. (2017). 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut and Liver, 11(1), 27–37. https://doi.org/10.5009/gnl15502 [accessed 13 August 2026]
2. Katz, P. O., Gerson, L. B., & Vela, M. F. (2013). Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology, 108(3), 308–328. https://doi.org/10.1038/ajg.2012.444 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (Clinical guideline CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
4. Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., & Brockmöller, J. (2009). Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH. European Journal of Clinical Pharmacology, 65(1), 19–31. https://doi.org/10.1007/s00228-008-0576-5 [accessed 13 August 2026]
5. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.